Publications
37
Citations
1,244
Est. group size
~1
Recurring co-author estimate
Active years
10
Publishing since 2017
Bihui Cao studies engineered cell-based cancer immunotherapies, particularly CAR-T and CAR-natural killer (NK) cells designed to target proteins found on tumors such as liver, lung, ovarian, and gastric cancers. The work also combines these therapies with local treatments like microwave ablation and explores drug-delivery approaches such as hydrogels and nanobodies, including applications in heart tissue repair. The overall aim is to make immune cells and related treatments more effective against cancer and other diseases.
Publication activity has grown notably in recent years, with output rising from a few papers annually to roughly 5 per year over the last five years and peaks in 2021, 2024, and 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Intrapericardial delivery of FAP-CAR-T cells via a ROS-responsive hydrogel to treat cardiac fibrosis
Journal of Controlled Release · 2026
- Luteolin enhances antitumor immunity of B7-H3-targeted bispecific natural killer cell engagers against non-small cell lung cancer
International Journal of Biological Sciences · 2026
- Effect of step-wise sintering temperature on the phase structure and electrochemical properties of (La, Mg)2Ni7 superlattice hydrogen storage alloys
International Journal of Electrochemical Science · 2026
- Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions
The Journal of Immunology · 2025
- IL-1β targeted nanobody promotes cardiac repair through IL10-STAT3 axon-dependent M2 macrophage polarization
International Journal of Biological Macromolecules · 2025
- CV1-secreting sCAR-T cells potentiate the abscopal effect of microwave ablation in heterogeneous tumors
Cell Reports Medicine · 2025
- CV1-Secreting sCAR-T Cells Potentiate the Abscopal Effect of Microwave Ablation in Heterogeneous Tumors
SSRN Electronic Journal · 2025
- Combining Microwave Ablation With CAR-T-Cell Therapy in Tumor-Bearing Mouse Models
BIO-PROTOCOL · 2025
- Photothermal-Triggered Extracellular Matrix Clearance and Dendritic Cell Maturation for Enhanced Osteosarcoma Immunotherapy
ACS Applied Materials & Interfaces · 2024
- NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
International Journal of Biological Sciences · 2024
- Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
Liver International · 2024
- Injection of ROS-Responsive Hydrogel Loaded with IL-1β-targeted nanobody for ameliorating myocardial infarction
Bioactive Materials · 2024
- Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma
Journal of Leukocyte Biology · 2024
- Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study
Cancer Imaging · 2023
- Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer
Translational Oncology · 2023
- International Journal of Biological Sciences×3
- SSRN Electronic Journal×3
- Journal of Hematology & Oncology×2
- Research Square×2
- Frontiers in Immunology×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile